{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:30:42Z","timestamp":1764937842485,"version":"3.32.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,28]]},"DOI":"10.7759\/cureus.76542","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T01:16:51Z","timestamp":1735435011000},"source":"Crossref","is-referenced-by-count":2,"title":["C-Reactive Protein\/Albumin Ratio and Clinicopathological Features in Ovarian Cancer: A Prospective Study"],"prefix":"10.7759","author":[{"given":"Archana","family":"Barik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apoorva","family":"Rashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitabh","family":"Kumar Upadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-249. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_1426_22","article-title":"Ovarian cancer: a report from population-based cancer registry at central rural India","volume":"19","author":"Gangane NM","year":"2023","unstructured":"Gangane NM, Patil BU, Ghongade PV. Ovarian cancer: a report from population-based cancer registry at central rural India. J Cancer Res Ther. 2023, 19:S857-S862. 10.4103\/jcrt.jcrt_1426_22","journal-title":"J Cancer Res Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10080251","article-title":"The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer","volume":"10","author":"Savant SS","year":"2018","unstructured":"Savant SS, Sriramkumar S, O'Hagan HM. The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer. Cancers (Basel). 2018, 10:251. 10.3390\/cancers10080251","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.03.035","article-title":"Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis","volume":"191","author":"Modugno F","year":"2004","unstructured":"Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol. 2004, 191:733-740. 10.1016\/j.ajog.2004.03.035","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0976","article-title":"Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study","volume":"19","author":"Prizment AE","year":"2010","unstructured":"Prizment AE, Folsom AR, Anderson KE. Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2010, 19:435-442. 10.1158\/1055-9965.EPI-09-0976","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.122","article-title":"Use of inflammatory markers to guide cancer treatment","volume":"90","author":"Clarke SJ","year":"2011","unstructured":"Clarke SJ, Chua W, Moore M, et al.. Use of inflammatory markers to guide cancer treatment. Clin Pharmacol Ther. 2011, 90:475-478. 10.1038\/clpt.2011.122","journal-title":"Clin Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1044","article-title":"Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer","volume":"14","author":"Hefler LA","year":"2008","unstructured":"Hefler LA, Concin N, Hofstetter G, et al.. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res. 2008, 14:710-714. 10.1158\/1078-0432.CCR-07-1044","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/10408363.2011.599831","article-title":"Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer","volume":"48","author":"Allin KH","year":"2011","unstructured":"Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011, 48:155-170. 10.3109\/10408363.2011.599831","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-03290-5","article-title":"Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis","volume":"22","author":"Zhang W","year":"2024","unstructured":"Zhang W, Zhang Z, Qian L. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis. World J Surg Oncol. 2024, 22:8. 10.1186\/s12957-023-03290-5","journal-title":"World J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"9","author":"Gupta D","year":"2010","unstructured":"Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010, 9:69. 10.1186\/1475-2891-9-69","journal-title":"Nutr J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-011-0019-5","article-title":"Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer","volume":"29","author":"Asher V","year":"2012","unstructured":"Asher V, Lee J, Bali A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol. 2012, 29:2005-2009. 10.1007\/s12032-011-0019-5","journal-title":"Med Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.07.005","article-title":"Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery","volume":"138","author":"Ataseven B","year":"2015","unstructured":"Ataseven B, du Bois A, Reinthaller A, et al.. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol. 2015, 138:560-565. 10.1016\/j.ygyno.2015.07.005","journal-title":"Gynecol Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4048-0","article-title":"The C-reactive protein\/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma","volume":"22","author":"Kinoshita A","year":"2015","unstructured":"Kinoshita A, Onoda H, Imai N, et al.. The C-reactive protein\/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015, 22:803-810. 10.1245\/s10434-014-4048-0","journal-title":"Ann Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2015.06.006","article-title":"Preoperative C-reactive protein\/albumin ratio predicts prognosis of patients after curative resection for gastric cancer","volume":"8","author":"Liu X","year":"2015","unstructured":"Liu X, Sun X, Liu J, Kong P, Chen S, Zhan Y, Xu D. Preoperative C-reactive protein\/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015, 8:339-345. 10.1016\/j.tranon.2015.06.006","journal-title":"Transl Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138657","article-title":"A novel inflammation-based prognostic score, the C-reactive protein\/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma","volume":"10","author":"Xu XL","year":"2015","unstructured":"Xu XL, Yu HQ, Hu W, Song Q, Mao WM. A novel inflammation-based prognostic score, the C-reactive protein\/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015, 10:e0138657. 10.1371\/journal.pone.0138657","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1379-6","article-title":"A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein\/albumin ratio","volume":"15","author":"Wei XL","year":"2015","unstructured":"Wei XL, Wang FH, Zhang DS, et al.. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein\/albumin ratio. BMC Cancer. 2015, 15:350. 10.1186\/s12885-015-1379-6","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3220-x","article-title":"The prognostic value of the preoperative c-reactive protein\/albumin ratio in ovarian cancer","volume":"17","author":"Liu Y","year":"2017","unstructured":"Liu Y, Chen S, Zheng C, et al.. The prognostic value of the preoperative c-reactive protein\/albumin ratio in ovarian cancer. BMC Cancer. 2017, 17:285. 10.1186\/s12885-017-3220-x","journal-title":"BMC Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2020.1798479","article-title":"Significance of pretreatment C-reactive protein, albumin, and C-reactive protein to albumin ratio in predicting poor prognosis in epithelial ovarian cancer patients","volume":"73","author":"Komura N","year":"2021","unstructured":"Komura N, Mabuchi S, Shimura K, Kawano M, Matsumoto Y, Kimura T. Significance of pretreatment C-reactive protein, albumin, and C-reactive protein to albumin ratio in predicting poor prognosis in epithelial ovarian cancer patients. Nutr Cancer. 2021, 73:1357-1364. 10.1080\/01635581.2020.1798479","journal-title":"Nutr Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737155","article-title":"Prognostic role of the C-reactive protein\/albumin ratio in patients with gynecological cancers: a meta-analysis","volume":"11","author":"Fang Y","year":"2021","unstructured":"Fang Y, Zheng T, Zhang C. Prognostic role of the C-reactive protein\/albumin ratio in patients with gynecological cancers: a meta-analysis. Front Oncol. 2021, 11:737155. 10.3389\/fonc.2021.737155","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.46799\/jhs.v4i5.913","article-title":"C-reactive protein\/albumin (Crp\/Alb) ratio as a predictor of ovarian cancer","volume":"4","author":"Budiana ING","year":"2023","unstructured":"Budiana ING, Mahendra INB, Wiradnyana AAGP, Darmayasa IM, Marta KF, Suwanpramana PM. C-reactive protein\/albumin (Crp\/Alb) ratio as a predictor of ovarian cancer. Jurnal Health Sains. 2023, 4:79-90. 10.46799\/jhs.v4i5.913","journal-title":"Jurnal Health Sains"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325710-c-reactive-proteinalbumin-ratio-and-clinicopathological-features-in-ovarian-cancer-a-prospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T01:16:52Z","timestamp":1735435012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325710-c-reactive-proteinalbumin-ratio-and-clinicopathological-features-in-ovarian-cancer-a-prospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.76542","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,28]]}}}